StockData
Stryker Corp logo

Stryker Corp (SYK) stock

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/308% below fair value
$317.54+6.82 (+2.19%)

Close on Nov 17, 2026Market cap $120.88BP/E 33.8Yield –

Stryker ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Stryker's ebitda for the twelve months ending Sep 30, 2026 was $7.05B, up 36.5% year over year. For fiscal 2025 it was $6.46B, up 26.3% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $6.46B in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.46B+26.3%
FY2024Dec 31, 2024$5.12B-2.2%
FY2023Dec 31, 2023$5.23B+26.9%
FY2022Dec 31, 2022$4.12B+6.8%
FY2021Dec 31, 2021$3.86B+16.9%
FY2020Dec 31, 2020$3.30B-12.2%
FY2019Dec 31, 2019$3.76B+7.3%
FY2018Dec 31, 2018$3.50B+11.0%
FY2017Dec 31, 2017$3.16B+7.8%
FY2016Dec 31, 2016$2.93B+19.4%
FY2015Dec 31, 2015$2.45B+33.8%
FY2014Dec 31, 2014$1.83B+3.7%
FY2013Dec 31, 2013$1.77B-20.7%
FY2012Dec 31, 2012$2.23B+2.8%
FY2011Dec 31, 2011$2.17B+0.3%
FY2010Dec 31, 2010$2.16B+9.2%
FY2009Dec 31, 2009$1.98B–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.43B-6.9%
Q2 FY2026Jun 30, 2026$2.06B+37.5%
Q1 FY2026Mar 31, 2026$1.33B+11.3%
Q4 FY2025Dec 31, 2025$2.22B+139.6%
Q3 FY2025Sep 30, 2025$1.54B+5.6%
Q2 FY2025Jun 30, 2025$1.50B+6.8%
Q1 FY2025Mar 31, 2025$1.20B-9.7%
Q4 FY2024Dec 31, 2024$927.00M–
Q3 FY2024Sep 30, 2024$1.46B–
Q2 FY2024Jun 30, 2024$1.41B–
Q1 FY2024Mar 31, 2024$1.33B–

More Stryker figures

See a number that looks wrong?